The FDA approved a new drug to help treat Alzheimer's disease Monday.
While it's bringing some people home, some experts have concerns over its effectiveness, side effects and cost.
The Market Is Rigged To Give All The Money To The Rich: The Case Of Covid Boosters – Analysis
It is much more acceptable in policy circles to talk about ways to make tax and transfer policy more progressive than ways to..
Eurasia Review